Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 56 15
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 50 20
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Metformin Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/20/2022 14 3
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 15 20
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 7 18
Fluvoxamine Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/18/2022 2 2
REGEN-COV Emergency use authorization Experimental Antiviral Aug/02/2022 21 4
CC12.1 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/15/2022 1 0
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 4
Excel (.xslx) CSV (.csv)